Saghmos Therapeutics, Inc.
Pharmaceutical company · Greenwich, Connecticut, United States
Saghmos Therapeutics, Inc. is a pharmaceutical company headquartered in Greenwich, Connecticut, United States. Its earliest recorded incorporation is in 2016. It has reported private securities offerings to the US SEC, most recently $3.5 million sold in a notice filed in 2018.
Saghmos Therapeutics at a glance
What does Saghmos Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $3.5 million sold (2018).
Frequently asked questions about Saghmos Therapeutics
Where is Saghmos Therapeutics headquartered?
Saghmos Therapeutics, Inc. is headquartered in Greenwich, Connecticut, United States.
What does Saghmos Therapeutics do?
Saghmos Therapeutics, Inc. is a pharmaceutical company.
When was Saghmos Therapeutics founded?
The earliest incorporation on record for Saghmos Therapeutics, Inc. is in 2016, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences